Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8630069 | Diabetes Research and Clinical Practice | 2018 | 20 Pages |
Abstract
Short-term CSII treatment can obtain glycemic control target and recover β-cell function and GLP-1 secretion in newly diagnosed type 2 diabetes patients. The overweight and middle-aged patients may get more benefit from this treatment.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Xiaofei Huang, Sha Li, Mei Yang, Xuquan Fu, Huaqi Li, Tong Yan, Yidong Liu, Lihong Chen, Lingsheng Lan, Libo Li, Xiaowei Zhong,